Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantovigar + Minoxidil in Female Pattern Hair Loss
NCT01900041Phase 2Completed
- Sponsor
- Merz
- Start
- Apr 2012
- Primary completion
- May 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Pantogar in androgenetic alopecia (AGA) (2 arms), sponsored by Merz. Primary endpoint: Rate of responders to the treatment. Started Apr 2012; status: completed.
02
Drugs
Pantogar
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT01900041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01900041.